{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:52:07Z","timestamp":1789984327991,"version":"4.0.1"},"reference-count":160,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T00:00:00Z","timestamp":1538006400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02146","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T05:08:20Z","timestamp":1538024900000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":57,"title":["Hypervariable Region 1 in Envelope Protein 2 of Hepatitis C Virus: A Linchpin in Neutralizing Antibody Evasion and Viral Entry"],"prefix":"10.3389","volume":"9","author":[{"given":"Jannick","family":"Prentoe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Bukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,9,27]]},"reference":[{"key":"B1","unstructured":"Hepatitis C. Fact Sheet Number 164.2017"},{"key":"B2","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.jhep.2016.07.035","article-title":"The history of hepatitis C virus (HCV): basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control","volume":"65","author":"Bukh","year":"2016","journal-title":"J Hepatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1016\/j.jhep.2015.02.006","article-title":"From non-A, non-B hepatitis to hepatitis C virus cure","volume":"62","author":"Pawlotsky","year":"2015","journal-title":"J Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1136\/gutjnl-2015-310421","article-title":"Hepatitis C virus treatment in the real world: optimising treatment and access to therapies","volume":"64","author":"Zoulim","year":"2015","journal-title":"Gut"},{"key":"B5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.virusres.2018.02.016","article-title":"Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: considerations for scientists and funding agencies","volume":"248","author":"Bartenschlager","year":"2018","journal-title":"Virus Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1099\/jgv.0.000672","article-title":"ICT. V. Virus taxonomy profile: flaviviridae","volume":"98","author":"Simmonds","year":"2017","journal-title":"J Gen.Virol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1099\/jgv.0.000612","article-title":"Proposed update to the taxonomy of the genera Hepacivirus and Pegivirus within the Flaviviridae family","volume":"97","author":"Smith","year":"2016","journal-title":"J Gen.Virol."},{"key":"B8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/JVI.71.1.697-704.1997","article-title":"Formation of native hepatitis C virus glycoprotein complexes","volume":"71","author":"Deleersnyder","year":"1997","journal-title":"J Virol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1128\/JVI.78.6.2994-3002.2004","article-title":"Characterization of functional hepatitis C virus envelope glycoproteins","volume":"78","author":"Op de Beeck","year":"2004","journal-title":"J Virol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1073\/pnas.0511218103","article-title":"Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro","volume":"103","author":"Lindenbach","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1136\/gutjnl-2015-310300","article-title":"HVR1-mediated antibody evasion of highly infectious in vivo adapted HCV in humanised mice","volume":"65","author":"Prentoe","year":"2016","journal-title":"Gut"},{"key":"B12","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.antiviral.2018.07.014","article-title":"Current status and future development of infectious cell-culture models for the major genotypes of hepatitis C virus: essential tools in testing of antivirals and emerging vaccine strategies","volume":"158","author":"Ramirez","year":"2018","journal-title":"Antiviral Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"Lindenbach","year":"2005","journal-title":"Science"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1053\/j.gastro.2007.08.005","article-title":"Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a\/2a (S52\/JFH1) viruses","volume":"133","author":"Gottwein","year":"2007","journal-title":"Gastroenterology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1086\/593021","article-title":"Highly efficient JFH1-based cell-culture system for hepatitis C virus genotype 5a: failure of homologous neutralizing-antibody treatment to control infection","volume":"198","author":"Jensen","year":"2008","journal-title":"J Infect Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1073\/pnas.0711044105","article-title":"Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization","volume":"105","author":"Scheel","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B18","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/hep.22673","article-title":"Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs","volume":"49","author":"Gottwein","year":"2009","journal-title":"Hepatology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"7408","DOI":"10.1073\/pnas.0504877103","article-title":"Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras","volume":"103","author":"Pietschmann","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/hep.27298","article-title":"Breadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3a","volume":"60","author":"Carlsen","year":"2014","journal-title":"Hepatology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"8913","DOI":"10.1128\/JVI.00049-11","article-title":"Development and application of hepatitis C reporter viruses with genotype 1 to 7 core-nonstructural protein 2 (NS2) expressing fluorescent proteins or luciferase in modified JFH1 NS5A","volume":"85","author":"Gottwein","year":"2011","journal-title":"J Virol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1084\/jem.20021756","article-title":"Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes","volume":"197","author":"Bartosch","year":"2003","journal-title":"J Exp Med."},{"key":"B23","unstructured":"Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles727176 HsuM ZhangJ FlintM LogvinoffC Cheng-MayerC RiceCM 10.1073\/pnas.083218010012761383Proc Natl Acad Sci USA1002003"},{"key":"B24","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0014-5793(03)00635-5","article-title":"Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins","volume":"546","author":"Drummer","year":"2003","journal-title":"FEBS Lett."},{"key":"B25","doi-asserted-by":"publisher","first-page":"13783","DOI":"10.1128\/JVI.01091-07","article-title":"Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture","volume":"81","author":"Chang","year":"2007","journal-title":"J Virol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1074\/jbc.M110.175018","article-title":"Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome","volume":"286","author":"Merz","year":"2011","journal-title":"J Biol Chem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"9505","DOI":"10.1073\/pnas.1307527110","article-title":"Ultrastructural analysis of hepatitis C virus particles","volume":"110","author":"Catanese","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B28","doi-asserted-by":"publisher","first-page":"9647","DOI":"10.1128\/JVI.00914-08","article-title":"Apolipoprotein c1 association with hepatitis C virus","volume":"82","author":"Meunier","year":"2008","journal-title":"J Virol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"12680","DOI":"10.1128\/JVI.01476-09","article-title":"Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles","volume":"83","author":"Jiang","year":"2009","journal-title":"J Virol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1073\/pnas.0700760104","article-title":"Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins","volume":"104","author":"Huang","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"B31","doi-asserted-by":"publisher","first-page":"11074","DOI":"10.1128\/JVI.01150-06","article-title":"Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles","volume":"80","author":"Gastaminza","year":"2006","journal-title":"J Virol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"6919","DOI":"10.1128\/JVI.76.14.6919-6928.2002","article-title":"Characterization of low- and very-low-density hepatitis C virus RNA-containing particles","volume":"76","author":"Andre","year":"2002","journal-title":"J Virol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1128\/JVI.80.5.2418-2428.2006","article-title":"Association between hepatitis C virus and very-low-density lipoprotein (VLDL)\/LDL analyzed in iodixanol density gradients","volume":"80","author":"Nielsen","year":"2006","journal-title":"J Virol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1053\/j.gastro.2010.06.058","article-title":"Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes","volume":"139","author":"Podevin","year":"2010","journal-title":"Gastroenterology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1053\/j.gastro.2015.09.014","article-title":"Apolipoprotein E mediates evasion from hepatitis C virus neutralizing antibodies","volume":"150","author":"Fauvelle","year":"2016","journal-title":"Gastroenterology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jhep.2017.04.010","article-title":"Maturation of secreted HCV particles by incorporation of secreted ApoE protects from antibodies by enhancing infectivity","volume":"67","author":"Bankwitz","year":"2017","journal-title":"J Hepatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1073\/pnas.0501275102","article-title":"Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1","volume":"102","author":"Meunier","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B38","doi-asserted-by":"publisher","first-page":"32357","DOI":"10.1074\/jbc.M705358200","article-title":"The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus","volume":"282","author":"Dreux","year":"2007","journal-title":"J Biol Chem."},{"key":"B39","doi-asserted-by":"publisher","first-page":"6866","DOI":"10.1128\/JVI.03475-12","article-title":"Syndecan-1 serves as the major receptor for attachment of hepatitis C virus to the surfaces of hepatocytes","volume":"87","author":"Shi","year":"2013","journal-title":"J Virol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"7256","DOI":"10.1128\/JVI.07222-11","article-title":"Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate","volume":"86","author":"Jiang","year":"2012","journal-title":"J Virol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e01583","DOI":"10.1128\/JVI.01583-16","article-title":"TIM-1 promotes hepatitis C virus cell attachment and infection","volume":"91","author":"Wang","year":"2017","journal-title":"J Virol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"key":"B43","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.1093\/emboj\/cdf529","article-title":"The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus","volume":"21","author":"Scarselli","year":"2002","journal-title":"EMB O J."},{"key":"B44","doi-asserted-by":"publisher","first-page":"41624","DOI":"10.1074\/jbc.M305289200","article-title":"Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor","volume":"278","author":"Bartosch","year":"2003","journal-title":"J Biol Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1002\/hep.21994","article-title":"Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81","volume":"46","author":"Zeisel","year":"2007","journal-title":"Hepatology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"12766","DOI":"10.1073\/pnas.96.22.12766","article-title":"Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor","volume":"96","author":"Agnello","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"B47","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jhep.2006.09.024","article-title":"The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus","volume":"46","author":"Molina","year":"2007","journal-title":"J.Hepatol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/hep.25501","article-title":"Role of low-density lipoprotein receptor in the hepatitis C virus life cycle","volume":"55","author":"Albecka","year":"2012","journal-title":"Hepatology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nature05654","article-title":"Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry","volume":"446","author":"Evans","year":"2007","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/nature07684","article-title":"Human occludin is a hepatitis C virus entry factor required for infection of mouse cells","volume":"457","author":"Ploss","year":"2009","journal-title":"Nature"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e01982","DOI":"10.1128\/JVI.01982-17","article-title":"Identification of piperazinylbenzenesulfonamides as new inhibitors of Claudin-1 trafficking and hepatitis C virus entry","volume":"92","author":"Riva","year":"2018","journal-title":"J Virol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nm.2581","article-title":"Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor","volume":"18","author":"Sainz","year":"2012","journal-title":"Nat Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nm.2341","article-title":"EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy","volume":"17","author":"Lupberger","year":"2011","journal-title":"Nat Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"8433","DOI":"10.1128\/JVI.00081-14","article-title":"Cell death-inducing DFFA-like effector b is required for hepatitis C virus entry into hepatocytes","volume":"88","author":"Wu","year":"2014","journal-title":"J Virol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e1006916","DOI":"10.1371\/journal.ppat.1006916","article-title":"Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma","volume":"14","author":"Sekhar","year":"2018","journal-title":"PLoS Pathog."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e00280","DOI":"10.1128\/JVI.00280-17","article-title":"Attachment and postattachment receptors important for hepatitis C virus infection and cell-to-cell transmission","volume":"91","author":"Fan","year":"2017","journal-title":"J Virol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e1005610","DOI":"10.1371\/journal.ppat.1005610","article-title":"Lipoprotein receptors redundantly participate in entry of hepatitis C virus","volume":"12","author":"Yamamoto","year":"2016","journal-title":"PLoS Pathog."},{"key":"B58","doi-asserted-by":"publisher","first-page":"5751","DOI":"10.1128\/JVI.02200-09","article-title":"Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes","volume":"84","author":"Bankwitz","year":"2010","journal-title":"J Virol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"12644","DOI":"10.1128\/JVI.01145-14","article-title":"Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins","volume":"88","author":"Bankwitz","year":"2014","journal-title":"J Virol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1128\/JVI.02017-13","article-title":"Hypervariable region 1 deletion and required adaptive envelope mutations confer decreased dependency on scavenger receptor class B type I and low-density lipoprotein receptor for hepatitis C virus","volume":"88","author":"Prentoe","year":"2014","journal-title":"J Virol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1128\/JVI.01134-06","article-title":"Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I","volume":"81","author":"Kapadia","year":"2007","journal-title":"J Virol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1002\/hep.27013","article-title":"Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses","volume":"59","author":"Osburn","year":"2014","journal-title":"Hepatology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.1073\/pnas.0607026104","article-title":"Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C","volume":"104","author":"Pestka","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1053\/j.gastro.2009.02.080","article-title":"Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus","volume":"136","author":"Dowd","year":"2009","journal-title":"Gastroenterology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"6023","DOI":"10.1128\/JVI.79.10.6023-6034.2005","article-title":"Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection","volume":"79","author":"Lavillette","year":"2005","journal-title":"J Virol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1053\/j.gastro.2006.12.008","article-title":"Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo","volume":"132","author":"von","year":"2007","journal-title":"Gastroenterology"},{"key":"B67","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1128\/JVI.68.3.1494-1500.1994","article-title":"Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses","volume":"68","author":"Shimizu","year":"1994","journal-title":"J Virol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/hep.21959","article-title":"Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies","volume":"47","author":"Timpe","year":"2008","journal-title":"Hepatology"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.3389\/fimmu.2018.01436","article-title":"Hepatitis C Virus (HCV)-apolipoprotein interactions and immune evasion and their impact on HC. V. vaccine design","volume":"9","author":"Wrensch","year":"2018","journal-title":"Front Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1172\/JCI78794","article-title":"Naturally selected hepatitis C virus polymorphisms confer broad neutralizing antibody resistance","volume":"125","author":"Bailey","year":"2015","journal-title":"J Clin Invest"},{"key":"B71","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1128\/JVI.02837-15","article-title":"A Hepatitis C virus envelope polymorphism confers resistance to neutralization by polyclonal sera and broadly neutralizing monoclonal antibodies","volume":"90","author":"Wasilewski","year":"2016","journal-title":"J Virol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"e1006235","DOI":"10.1371\/journal.ppat.1006235","article-title":"Extra-epitopic hepatitis C virus polymorphisms confer resistance to broadly neutralizing antibodies by modulating binding to scavenger receptor B1","volume":"13","author":"El-Diwany","year":"2017","journal-title":"PLoS Pathog."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.3389\/fimmu.2018.01703","article-title":"Defining breadth of hepatitis C virus neutralization","volume":"9","author":"Kinchen","year":"2018","journal-title":"Front Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"8101","DOI":"10.1128\/JVI.00127-07","article-title":"The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein","volume":"81","author":"Helle","year":"2007","journal-title":"J Virol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"11905","DOI":"10.1128\/JVI.01548-10","article-title":"Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions","volume":"84","author":"Helle","year":"2010","journal-title":"J Virol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"8072","DOI":"10.1128\/JVI.00459-07","article-title":"Hepatitis C virus envelope glycoprotein E2 glycans modulate entry, CD81 binding, and neutralization","volume":"81","author":"Falkowska","year":"2007","journal-title":"J Virol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"910","DOI":"10.3389\/fimmu.2018.00910","article-title":"Glycan shielding and modulation of hepatitis C virus neutralizing antibodies","volume":"9","author":"Lavie","year":"2018","journal-title":"Front Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"8217","DOI":"10.1128\/JVI.79.13.8217-8229.2005","article-title":"An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies","volume":"79","author":"Bartosch","year":"2005","journal-title":"J Virol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1128\/JVI.01594-10","article-title":"Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization","volume":"85","author":"Prentoe","year":"2011","journal-title":"J Virol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1128\/JVI.01872-07","article-title":"Isolation and characterization of broadly neutralizing human monoclonal antibodies to the e1 glycoprotein of hepatitis C virus","volume":"82","author":"Meunier","year":"2008","journal-title":"J Virol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"9224","DOI":"10.1128\/JVI.78.17.9224-9232.2004","article-title":"Hepatitis C virus E2 has three immunogenic domains containing conformational epitopes with distinct properties and biological functions","volume":"78","author":"Keck","year":"2004","journal-title":"J Virol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e1002653","DOI":"10.1371\/journal.ppat.1002653","article-title":"Human monoclonal antibodies to a novel cluster of conformational epitopes on HC. V. E2 with resistance to neutralization escape in a genotype 2a isolate","volume":"8","author":"Keck","year":"2012","journal-title":"PLoS Pathog."},{"key":"B83","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1128\/JVI.01941-12","article-title":"Cooperativity in virus neutralization by human monoclonal antibodies to two adjacent regions located at the amino terminus of hepatitis C virus E2 glycoprotein","volume":"87","author":"Keck","year":"2013","journal-title":"J Virol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nm1698","article-title":"Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge","volume":"14","author":"Law","year":"2008","journal-title":"Nat Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"6205","DOI":"10.1073\/pnas.1114927109","article-title":"Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus","volume":"109","author":"Giang","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B86","doi-asserted-by":"publisher","first-page":"10407","DOI":"10.1128\/JVI.74.22.10407-10416.2000","article-title":"Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes","volume":"74","author":"Hadlock","year":"2000","journal-title":"J Virol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"6061","DOI":"10.1128\/JVI.02475-07","article-title":"Definition of a conserved immunodominant domain on hepatitis C virus E2 glycoprotein by neutralizing human monoclonal antibodies","volume":"82","author":"Keck","year":"2008","journal-title":"J Virol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"7005","DOI":"10.1128\/JVI.00586-11","article-title":"Neutralizing monoclonal antibodies against hepatitis C virus E2 protein bind discontinuous epitopes and inhibit infection at a postattachment step","volume":"85","author":"Sabo","year":"2011","journal-title":"J Virol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"11095","DOI":"10.1128\/JVI.79.17.11095-11104.2005","article-title":"Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein","volume":"79","author":"Owsianka","year":"2005","journal-title":"J Virol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/hep.21088","article-title":"Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33","volume":"43","author":"Tarr","year":"2006","journal-title":"Hepatology"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.3389\/fimmu.2018.01194","article-title":"Mapping determinants of virus neutralization and viral escape for rational design of a hepatitis C virus vaccine","volume":"9","author":"Keck","year":"2018","journal-title":"Front Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/0042-6822(91)90104-J","article-title":"Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins","volume":"180","author":"Weiner","year":"1991","journal-title":"Virology"},{"key":"B93","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0006-291X(05)81223-9","article-title":"Hypervariable regions in the putative glycoprotein of hepatitis C virus","volume":"175","author":"Hijikata","year":"1991","journal-title":"Biochem Biophys Res Commun."},{"key":"B94","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1073\/pnas.88.8.3392","article-title":"Nucleotide sequence and mutation rate of the H strain of hepatitis C virus","volume":"88","author":"Ogata","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"B95","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0168-8278(05)80226-0","article-title":"The hypervariable region of the HCV genome changes sequentially during the progression of acute HCV infection to chronic hepatitis","volume":"17","author":"Enomoto","year":"1993","journal-title":"J Hepatol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/jmv.1890420119","article-title":"Sequential change of the hypervariable region of the hepatitis C virus genome in acute infection","volume":"42","author":"Sakamoto","year":"1994","journal-title":"J Med Virol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/hep.1840180602","article-title":"Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection","volume":"18","author":"Kurosaki","year":"1993","journal-title":"Hepatology"},{"key":"B98","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1073\/pnas.89.8.3468","article-title":"Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections","volume":"89","author":"Weiner","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"B99","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1128\/JVI.72.6.4893-4905.1998","article-title":"Long-term evolution of the hypervariable region of hepatitis C virus in a common-source-infected cohort","volume":"72","author":"McAllister","year":"1998","journal-title":"J Virol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1128\/JVI.74.6.2541-2549.2000","article-title":"Evolutionary rate and genetic drift of hepatitis C virus are not correlated with the host immune response: studies of infected donor-recipient clusters","volume":"74","author":"Allain","year":"2000","journal-title":"J Virol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1128\/JVI.02995-15","article-title":"Network analysis of the chronic hepatitis C virome defines hypervariable region 1 evolutionary phenotypes in the context of humoral immune responses","volume":"90","author":"Palmer","year":"2015","journal-title":"J Virol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1099\/vir.0.000149","article-title":"Intensive temporal mapping of hepatitis C hypervariable region 1 quasispecies provides novel insights into hepatitis C virus evolution in chronic infection","volume":"96","author":"Schmidt-Martin","year":"2015","journal-title":"J Gen Virol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.meegid.2009.05.007","article-title":"The role of positive selection in hepatitis C virus","volume":"9","author":"Cuevas","year":"2009","journal-title":"Infect Genet Evol."},{"key":"B104","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/(SICI)1096-9071(199701)51:1<67::AID-JMV11>3.0.CO;2-1","article-title":"Reactivity of synthetic peptides representing selected sections of hepatitis C virus core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma","volume":"51","author":"Jackson","year":"1997","journal-title":"J Med Virol."},{"key":"B105","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1128\/JVI.71.5.4123-4127.1997","article-title":"Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus","volume":"71","author":"Zibert","year":"1997","journal-title":"J Virol."},{"key":"B106","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1128\/JVI.69.7.4407-4412.1995","article-title":"Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients","volume":"69","author":"Scarselli","year":"1995","journal-title":"J Virol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/BF01384335","article-title":"The serology of hepatitis C virus (HCV) infection: antibody crossreaction in the hypervariable region 1","volume":"140","author":"da","year":"1995","journal-title":"Arch Virol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/hep.510300233","article-title":"Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation","volume":"30","author":"Mondelli","year":"1999","journal-title":"Hepatology"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1002\/hep.510270629","article-title":"Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease","volume":"27","author":"Brambilla","year":"1998","journal-title":"Hepatology"},{"key":"B110","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1128\/JVI.67.7.3923-3930.1993","article-title":"Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus","volume":"67","author":"Kato","year":"1993","journal-title":"J Virol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/hep.510250530","article-title":"Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus","volume":"25","author":"Zibert","year":"1997","journal-title":"Hepatology"},{"key":"B112","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1126\/science.288.5464.339","article-title":"The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies","volume":"288","author":"Farci","year":"2000","journal-title":"Science"},{"key":"B113","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1006\/viro.1993.1378","article-title":"A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2\/NS1 protein: implication for an escape from antibody","volume":"195","author":"Taniguchi","year":"1993","journal-title":"Virology"},{"key":"B114","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1128\/JVI.68.8.4776-4784.1994","article-title":"Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection","volume":"68","author":"Kato","year":"1994","journal-title":"J Virol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/0016-5085(94)90770-6","article-title":"Hypervariable region of hepatitis C virus envelope glycoprotein (E2\/NS1) in an agammaglobulinemic patient","volume":"106","author":"Kumar","year":"1994","journal-title":"Gastroenterology"},{"key":"B116","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1086\/513995","article-title":"Variation of hepatitis C virus hypervariable region 1 in immunocompromised patients","volume":"175","author":"Odeberg","year":"1997","journal-title":"J Infect Dis."},{"key":"B117","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/hep.510270134","article-title":"Comparison of the rate of sequence variation in the hypervariable region of E2\/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients","volume":"27","author":"Booth","year":"1998","journal-title":"Hepatology"},{"key":"B118","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/jmv.10296","article-title":"Changes in hypervariable region 1 of the envelope 2 glycoprotein of hepatitis C virus in children and adults with humoral immune defects","volume":"69","author":"Gaud","year":"2003","journal-title":"J Med Virol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1086\/432917","article-title":"Reemergence of hepatitis C virus after 8","volume":"192","author":"Lee","year":"2005","journal-title":"J Infect Dis."},{"key":"B120","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1099\/vir.0.028092-0","article-title":"Characterization of antibody-mediated neutralization directed against the hypervariable region 1 of hepatitis C virus E2 glycoprotein","volume":"92","author":"Vieyres","year":"2011","journal-title":"J Gen Virol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"35631","DOI":"10.1074\/jbc.M112.382341","article-title":"Three different functional microdomains in the hepatitis C virus hypervariable region 1 (HVR1) mediate entry and immune evasion","volume":"287","author":"Guan","year":"2012","journal-title":"J Biol Chem."},{"key":"B122","doi-asserted-by":"publisher","first-page":"5703","DOI":"10.1128\/JVI.75.12.5703-5710.2001","article-title":"Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment","volume":"75","author":"Penin","year":"2001","journal-title":"J Virol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/hep.20268","article-title":"A critical role for the chimpanzee model in the study of hepatitis C","volume":"39","author":"Bukh","year":"2004","journal-title":"Hepatology"},{"key":"B124","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000050040","article-title":"Studies of hepatitis C virus in chimpanzees and their importance for vaccine development","volume":"44","author":"Bukh","year":"2001","journal-title":"Intervirology"},{"key":"B125","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/ilar\/ilx028","article-title":"The chimpanzee model of viral hepatitis: advances in understanding the immune response and treatment of viral hepatitis","volume":"58","author":"Lanford","year":"2017","journal-title":"ILAR J."},{"key":"B126","doi-asserted-by":"publisher","first-page":"15394","DOI":"10.1073\/pnas.93.26.15394","article-title":"Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein","volume":"93","author":"Farci","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"B127","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1128\/JVI.69.2.773-778.1995","article-title":"Sequence evolution of the hypervariable region in the putative envelope region E2\/NS1 of hepatitis C virus is correlated with specific humoral immune responses","volume":"69","author":"van","year":"1995","journal-title":"J Virol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1128\/JVI.74.7.3058-3066.2000","article-title":"Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees","volume":"74","author":"Ray","year":"2000","journal-title":"J Virol."},{"key":"B129","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1128\/JVI.72.4.2589-2599.1998","article-title":"Analysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profiles","volume":"72","author":"Bassett","year":"1998","journal-title":"J Virol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1056\/NEJM199212313272702","article-title":"The natural history of community-acquired hepatitis C in the United States. The sentinel counties chronic non-A, non-B hepatitis study team","volume":"327","author":"Alter","year":"1992","journal-title":"N Engl J Med."},{"key":"B131","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1128\/JVI.73.2.1118-1126.1999","article-title":"Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees","volume":"73","author":"Bassett","year":"1999","journal-title":"J Virol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"13318","DOI":"10.1073\/pnas.230453597","article-title":"Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees","volume":"97","author":"Forns","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"B133","doi-asserted-by":"publisher","first-page":"8183","DOI":"10.1128\/JVI.00142-08","article-title":"Previously infected chimpanzees are not consistently protected against reinfection or persistent infection after reexposure to the identical hepatitis C virus strain","volume":"82","author":"Bukh","year":"2008","journal-title":"J Virol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1006\/viro.2000.0419","article-title":"Characterization of modified hepatitis C virus E2 proteins expressed on the cell surface","volume":"274","author":"Forns","year":"2000","journal-title":"Virology"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1002\/hep.28705","article-title":"Hypervariable region 1 shielding of hepatitis C virus is a main contributor to genotypic differences in neutralization sensitivity","volume":"64","author":"Prentoe","year":"2016","journal-title":"Hepatology"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1002\/hep.28760","article-title":"Hepatitis C virus plays hide and seek with neutralizing antibodies","volume":"64","author":"Bankwitz","year":"2016","journal-title":"Hepatology"},{"key":"B137","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1128\/JVI.02458-15","article-title":"Antibody response to hypervariable region 1 interferes with broadly neutralizing antibodies to hepatitis C virus","volume":"90","author":"Keck","year":"2016","journal-title":"J Virol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"e1006214","DOI":"10.1371\/journal.ppat.1006214","article-title":"Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A","volume":"13","author":"Velazquez-Moctezuma","year":"2017","journal-title":"PLoS Pathog."},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy481","article-title":"Hepatitis C virus escape studies for human monoclonal antibody AR4A reveal isolate-specific resistance and a high barrier to resistance","author":"Velazquez-Moctezuma","year":"2018","journal-title":"J Infect Dis."},{"key":"B140","doi-asserted-by":"publisher","first-page":"e01668","DOI":"10.1128\/JVI.01668-16","article-title":"An optimized hepatitis C virus E2 glycoprotein core adopts a functional homodimer that efficiently blocks virus entry","volume":"91","author":"McCaffrey","year":"2017","journal-title":"J Virol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"12245","DOI":"10.1128\/JVI.02070-15","article-title":"Monoclonal antibodies directed toward the hepatitis C virus glycoprotein E2 detect antigenic differences modulated by the N-terminal hypervariable region 1 (HVR1), HVR2, and intergenotypic variable region","volume":"89","author":"Alhammad","year":"2015","journal-title":"J Virol."},{"key":"B142","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1128\/JVI.73.4.2938-2946.1999","article-title":"Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy","volume":"73","author":"Ray","year":"1999","journal-title":"J Virol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1006\/bbrc.1997.7693","article-title":"Differences in hypervariable region 1 quasispecies between immune complexed and non-immune complexed hepatitis C virus particles","volume":"240","author":"Korenaga","year":"1997","journal-title":"Biochem Biophys Res Commun."},{"key":"B144","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1046\/j.1365-2893.2001.00305.x","article-title":"A possible role of hypervariable region 1 quasispecies in escape of hepatitis C virus particles from neutralization","volume":"8","author":"Korenaga","year":"2001","journal-title":"J Viral Hepat."},{"key":"B145","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.virol.2010.10.034","article-title":"Hepatitis C virus expressing flag-tagged envelope protein 2 has unaltered infectivity and density, is specifically neutralized by flag antibodies and can be purified by affinity chromatography","volume":"409","author":"Prentoe","year":"2011","journal-title":"Virology"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1128\/JVI.77.3.1856-1867.2003","article-title":"Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2","volume":"77","author":"Roccasecca","year":"2003","journal-title":"J Virol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"7793","DOI":"10.1074\/jbc.M411600200","article-title":"High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I","volume":"280","author":"Voisset","year":"2005","journal-title":"J Biol Chem."},{"key":"B148","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1099\/vir.0.81932-0","article-title":"High-density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entry","volume":"87","author":"Voisset","year":"2006","journal-title":"J Gen Virol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"18285","DOI":"10.1074\/jbc.M602706200","article-title":"High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI","volume":"281","author":"Dreux","year":"2006","journal-title":"J Biol Chem."},{"key":"B150","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1096\/fj.05-4728fje","article-title":"The interaction of natural hepatitis C virus with human scavenger receptor SR-BI\/Cla1 is mediated by ApoB-containing lipoproteins","volume":"20","author":"Maillard","year":"2006","journal-title":"FASE B J."},{"key":"B151","doi-asserted-by":"publisher","first-page":"31242","DOI":"10.1074\/jbc.M112.365924","article-title":"Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps","volume":"287","author":"Dao","year":"2012","journal-title":"J Biol Chem."},{"key":"B152","doi-asserted-by":"publisher","first-page":"7758","DOI":"10.1128\/JVI.00039-15","article-title":"Adaptive mutations enhance assembly and cell-to-cell transmission of a high-titer hepatitis c virus genotype 5a Core-NS2 JFH1-based recombinant","volume":"89","author":"Mathiesen","year":"2015","journal-title":"J Virol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"12020","DOI":"10.1128\/JVI.01569-08","article-title":"Identification of a residue in hepatitis C virus E2 glycoprotein that determines scavenger receptor BI and CD81 receptor dependency and sensitivity to neutralizing antibodies","volume":"82","author":"Grove","year":"2008","journal-title":"J Virol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"5494","DOI":"10.1128\/JVI.02153-09","article-title":"Mutations within a conserved region of the hepatitis C virus E2 glycoprotein that influence virus-receptor interactions and sensitivity to neutralizing antibodies","volume":"84","author":"Dhillon","year":"2010","journal-title":"J Virol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.virol.2009.09.006","article-title":"A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles","volume":"395","author":"Tao","year":"2009","journal-title":"Virology"},{"key":"B156","doi-asserted-by":"publisher","first-page":"4478","DOI":"10.1128\/JVI.78.9.4478-4486.2004","article-title":"The hypervariable region 1 of the E2 glycoprotein of hepatitis C virus binds to glycosaminoglycans, but this binding does not lead to infection in a pseudotype system","volume":"78","author":"Basu","year":"2004","journal-title":"J Virol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nature13117","article-title":"Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2","volume":"509","author":"Khan","year":"2014","journal-title":"Nature"},{"key":"B158","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1126\/science.1243876","article-title":"Hepatitis C virus E2 envelope glycoprotein core structure","volume":"342","author":"Kong","year":"2013","journal-title":"Science"},{"key":"B159","doi-asserted-by":"publisher","first-page":"e02141","DOI":"10.1128\/JVI.02141-17","article-title":"Role of the E2 hypervariable region (HVR1) in the immunogenicity of a recombinant hepatitis C virus vaccine","volume":"92","author":"Law","year":"2018","journal-title":"J.Virol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/hep.28989","article-title":"The core domain of hepatitis C virus glycoprotein E2 generates potent cross-neutralizing antibodies in guinea pigs","volume":"65","author":"Vietheer","year":"2017","journal-title":"Hepatology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02146\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T04:58:31Z","timestamp":1605070711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02146\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,27]]},"references-count":160,"alternative-id":["10.3389\/fimmu.2018.02146"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02146","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,27]]},"article-number":"2146"}}